These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 20625554)
1. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. Bryan MA; Guyach SE; Norris KA PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554 [TBL] [Abstract][Full Text] [Related]
2. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. Bermejo DA; Amezcua-Vesely MC; Montes CL; Merino MC; Gehrau RC; Cejas H; Acosta-Rodríguez EV; Gruppi A PLoS Negl Trop Dis; 2010 May; 4(5):e679. PubMed ID: 20454564 [TBL] [Abstract][Full Text] [Related]
3. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388 [TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. Tarleton RL; Grusby MJ; Zhang L J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759 [TBL] [Abstract][Full Text] [Related]
5. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL; Antúnez MI; Abrami AA Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248 [TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies. Bermejo DA; Amezcua Vesely MC; Khan M; Acosta Rodríguez EV; Montes CL; Merino MC; Toellner KM; Mohr E; Taylor D; Cunningham AF; Gruppi A Immunology; 2011 Jan; 132(1):123-33. PubMed ID: 20875075 [TBL] [Abstract][Full Text] [Related]
7. Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice. Tarleton RL; Scott DW Parasite Immunol; 1987 Sep; 9(5):579-89. PubMed ID: 2960943 [TBL] [Abstract][Full Text] [Related]
8. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response. Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332 [TBL] [Abstract][Full Text] [Related]
9. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. Kumar S; Tarleton RL J Immunol; 2001 Apr; 166(7):4596-603. PubMed ID: 11254717 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin-dependent regulation of Th1 and Th17 cytokine responses in Trypanosoma cruzi-infected C57BL/6 mice. Santamaría MH; Corral RS Cytokine; 2013 Feb; 61(2):491-8. PubMed ID: 23199812 [TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. Hoft DF; Lynch RG; Kirchhoff LV J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708 [TBL] [Abstract][Full Text] [Related]
13. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089 [TBL] [Abstract][Full Text] [Related]
14. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction? Basso B; Marini V Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810 [TBL] [Abstract][Full Text] [Related]
15. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice. Gupta S; Garg NJ PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586 [TBL] [Abstract][Full Text] [Related]
17. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Hoft DF; Eickhoff CS Infect Immun; 2002 Dec; 70(12):6715-25. PubMed ID: 12438346 [TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. Zuñiga E; Motran CC; Montes CL; Yagita H; Gruppi A J Immunol; 2002 Apr; 168(8):3965-73. PubMed ID: 11937553 [TBL] [Abstract][Full Text] [Related]
19. Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response. Tarleton RL; Kuhn RE Cell Immunol; 1983 Sep; 80(2):392-404. PubMed ID: 6411359 [TBL] [Abstract][Full Text] [Related]
20. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]